In 1965, Intel co-founder Gordon Moore made a prediction about computing that has held true to this day. Moore’s law, as it came to be known, forecasted that the number of transistors we’d be able to cram onto a circuit—and thereby, the effective processing speed of our computers—would double roughly every two years. Remarkably enough, this rule has been accurate for nearly 50 years, but most experts now predict that this growth will slow by the end of the decade.
UC Santa Barbara scientists turned to the simple sponge to find clues about the evolution of the complex nervous system and found that, but for a mechanism that coordinates the expression of genes that lead to the formation of neural synapses, sponges and the rest of the animal world may not be so distant after all. Their findings, titled “Functionalization of a protosynaptic gene expression network,” are published in the Proceedings of the National Academy of Sciences.
Imagine being able to mathematically compute the entire process by which an embryo develops into an animal. Such a capability holds enormous promise for medicine, pointing to the potential for determining when and where development can go awry, and paving the way to possible solutions.
After an announcement by federal officials approving clinical trials for the drug Crenezumab, researchers searching for a way to treat Alzheimer’s Disease are gearing up for a rare study that will allow them to test a therapy for a genetically predestined disease - before its onset.
UC Santa Barbara researchers have discovered Salmonella bacteria that are up to 100 times more capable of causing disease. Their findings may help prevent food poisoning outbreaks that continue to plague public health and the food industry.
What if bacteria could talk to each other? What if they had a sense of touch? A new study by researchers at UC Santa Barbara suggests both, and theorizes that such cells may, in fact, need to communicate in order to perform certain functions. The findings appear today in the journal Genes & Development.
Pete Coffey, an internationally prominent researcher from Britain who works on stem cell biology and the prevention of blindness, will direct UCSB's Center for the Study of Macular Degeneration, and will also work with the university's Center for Stem Cell Biology and Engineering. Both centers are part of UCSB's Neuroscience Research Institute.
Scientists Make Strides Toward Drug Therapy for Inherited Kidney Disease Research in the laboratory of Thomas Weimbs in MCDB has led to the discovery that patients with an inherited kidney disease may be helped by a drug that is currently available for other uses. The findings are published in this week's issue of the Proceedings of the National Academy of Sciences.
MCDB scientist in collaboration with Sanford-Burnham and Salk Institute scientists combine tumor-targeting peptides and nanoparticles to eliminate glioblastoma in a previously untreatable mouse model.